November 8, 2018

Senseonics Holdings, Inc. Reports Third Quarter 2018 Financial Results

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the third quarter ended September 30, 2018. RECENT HIGHLIGHTS & ACCOMPLISHMENTS: Commercially launched Eversense in the U.S. and completed first commercial insertion Announced positive coverage decisi


Leave Comment


Your Name *
Your Email *
Your Website

Comment *